JAGUAR HEALTH, INC. (JAGX) Shareholder Equity
- 2026-06-30: Additional Paid in Capital, Common StockUSD $411.61M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.24M; Retained Earnings (Accumulated Deficit)USD $-403.75M; Stockholders' Equity, Including Portion Attributable to Noncontrolling InterestUSD $4.92M.
- 2026-03-31: Additional Paid in Capital, Common StockUSD $378.13M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.24M; Retained Earnings (Accumulated Deficit)USD $-391.07M; Stockholders' Equity, Including Portion Attributable to Noncontrolling InterestUSD $-15.75M.
- 2025-12-31: Additional Paid in Capital, Common StockUSD $380.97M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-833.00K; Retained Earnings (Accumulated Deficit)USD $-399.92M; Stockholders' Equity, Including Portion Attributable to Noncontrolling InterestUSD $-18.69M.
- 2025-09-30: Additional Paid in Capital, Common StockUSD $380.84M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-839.00K; Retained Earnings (Accumulated Deficit)USD $-376.86M; Stockholders' Equity, Including Portion Attributable to Noncontrolling InterestUSD $4.36M.
JAGUAR HEALTH, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Preferred Stock, Value, Outstanding USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD | Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD | Noncontrolling Interest, Increase from Business Combination USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $411.61M | $-1.24M | $-403.75M | $4.92M | (m) | 6 month · $4.00K | 3 month · $171.00K 6 month · $326.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $378.13M | $-1.24M | $-391.07M | $-15.75M | $0.00 | 3 month · $4.00K | 3 month · $155.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $380.97M | $-833.00K | $-399.92M | $-18.69M | $2.48M | 12 month · $323.00K | 12 month · $831.00K | 12 month · $4.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $380.84M | $-839.00K | $-376.86M | $4.36M | (m) | 9 month · $323.00K | 3 month · $135.00K 9 month · $715.00K | 9 month · $4.78M | (m) | 3 month · $160.00K 9 month · $477.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $373.57M | $-719.00K | $-367.35M | $6.88M | (m) | 3 month · $140.00K 6 month · $323.00K | 3 month · $279.00K 6 month · $580.00K | 3 month · $2.98M 6 month · $4.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $359.43M | $-700.00K | $-356.95M | $830.00K | (m) | 3 month · $183.00K | 3 month · $301.00K | 3 month · $1.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $354.23M | $-467.00K | $-346.48M | $6.49M | (m) | (m) | 12 month · $1.56M | (m) | (m) | 12 month · $727.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $350.86M | $-687.00K | $-336.56M | $13.10M | (m) | (m) | 3 month · $227.00K 9 month · $1.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $344.15M | $-542.00K | $-326.71M | $16.58M | (m) | (m) | 3 month · $383.00K 6 month · $964.00K | (m) | (m) | 3 month · $148.00K 6 month · $264.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $329.65M | $-461.00K | $-317.21M | $11.82M | (m) | (m) | 3 month · $581.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $313.86M | $-652.00K | $-308.25M | $4.90M | (m) | (m) | 12 month · $2.10M | (m) | 12 month · $1.23M | 12 month · $635.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $301.23M | $-796.00K | $-299.08M | $1.42M | (m) | (m) | 3 month · $528.00K 9 month · $1.53M | (m) | 9 month · $1.23M | 3 month · $755.00K 9 month · $755.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $297.66M | $-723.00K | $-291.30M | $5.83M | (m) | (m) | 3 month · $518.00K 6 month · $998.00K | (m) | 6 month · $1.23M | 3 month · $891.00K 6 month · $891.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $287.38M | $-884.00K | $-279.15M | $7.66M | (m) | (m) | 3 month · $480.00K | (m) | 3 month · $1.23M | 3 month · $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $266.97M | $-680.00K | $-266.95M | $-1.36M | (m) | (m) | 12 month · $3.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $263.00M | (m) | $-259.37M | $3.60M | (m) | (m) | 3 month · $741.00K 9 month · $2.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $249.55M | (m) | $-246.85M | $2.76M | (m) | (m) | 3 month · $1.02M 6 month · $2.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $245.52M | (m) | $-237.48M | $8.11M | (m) | (m) | 3 month · $1.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $231.10M | (m) | $-219.49M | $11.85M | (m) | (m) | 12 month · $3.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $247.00K |
| 2021-09-30 | $226.73M | (m) | $-205.18M | $21.55M | (m) | (m) | 3 month · $1.17M 9 month · $2.83M | (m) | (m) | (m) | (m) | (m) | $21.55M | (m) | (m) | (m) | (m) |
| 2021-06-30 | $224.76M | (m) | $-192.99M | $31.79M | (m) | (m) | 3 month · $1.03M 6 month · $1.67M | (m) | (m) | (m) | (m) | (m) | $31.79M | (m) | (m) | (m) | (m) |
| 2021-03-31 | $210.79M | (m) | $-178.91M | $31.89M | (m) | (m) | 3 month · $634.00K | (m) | (m) | (m) | (m) | (m) | $31.89M | (m) | (m) | (m) | (m) |
| 2020-12-31 | $184.10M | (m) | $-166.90M | $17.20M | (m) | (m) | 12 month · $2.82M | (m) | (m) | (m) | (m) | (m) | $17.20M | (m) | (m) | 12 month · $-1.33M | (m) |
| 2020-09-30 | $160.24M | (m) | $-158.13M | (m) | (m) | (m) | 3 month · $675.00K 9 month · $2.18M | (m) | (m) | (m) | (m) | (m) | $7.81M | (m) | (m) | 3 month · $349.00K 9 month · $1.33M | (m) |
| 2020-06-30 | $150.88M | (m) | $-150.26M | (m) | (m) | (m) | 3 month · $749.00K 6 month · $1.51M | 6 month · $494.00K | (m) | (m) | (m) | (m) | $1.54M | (m) | (m) | 3 month · $-503.00K 6 month · $-983.00K | (m) |
| 2020-03-31 | $145.86M | (m) | $-141.03M | (m) | (m) | (m) | 3 month · $760.00K | 3 month · $494.00K | (m) | (m) | (m) | (m) | $6.23M | (m) | (m) | (m) | (m) |
| 2019-12-31 | $142.05M | (m) | $-133.09M | $10.67M | (m) | (m) | 12 month · $2.99M | 12 month · $493.69K | (m) | (m) | (m) | (m) | $10.67M | (m) | (m) | 12 month · $-895.00K | (m) |
| 2019-09-30 | $138.10M | (m) | $-127.13M | (m) | (m) | (m) | 3 month · $1.11M 9 month · $1.98M | 9 month · $493.69K | (m) | (m) | $409.40K | (m) | $11.38M | (m) | (m) | (m) | (m) |
| 2019-06-30 | $117.93M | (m) | $-119.58M | (m) | (m) | (m) | 3 month · $446.00K 6 month · $873.00K | 6 month · $493.69K | (m) | (m) | (m) | (m) | $-1.65M | (m) | (m) | (m) | (m) |
| 2019-03-31 | $109.64M | (m) | $-102.85M | (m) | (m) | (m) | 3 month · $427.00K | 3 month · $493.69K | (m) | (m) | (m) | (m) | $6.79M | (m) | (m) | (m) | (m) |
| 2018-12-31 | $99.93M | (m) | $-94.55M | (m) | (m) | (m) | 12 month · $2.02M | 12 month · $118.15K | (m) | (m) | (m) | (m) | $5.38M | (m) | 12 month · $995.00K | (m) | (m) |
| 2018-09-30 | $92.22M | (m) | $-81.90M | (m) | (m) | (m) | 3 month · $680.09K 9 month · $1.42M | 3 month · $118.15K | (m) | (m) | (m) | (m) | $10.32M | (m) | 9 month · $995.00K | (m) | (m) |
| 2018-08-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $494.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $89.77M | (m) | $-75.76M | (m) | (m) | (m) | 3 month · $464.45K 6 month · $736.70K | (m) | (m) | (m) | (m) | (m) | $14.02M | 6 month · $995.00K | 6 month · $995.00K | (m) | (m) |
| 2018-03-31 | $89.09M | (m) | $-68.10M | (m) | (m) | (m) | 3 month · $272.24K | (m) | (m) | (m) | (m) | (m) | $21.01M | (m) | 3 month · $995.00K | (m) | (m) |
| 2017-12-31 | $79.66M | (m) | $-62.40M | (m) | (m) | (m) | 12 month · $814.61K | 12 month · $630.86K | (m) | (m) | (m) | (m) | $17.26M | (m) | (m) | (m) | (m) |
| 2017-09-30 | $74.00M | (m) | $-42.20M | (m) | (m) | (m) | 9 month · $630.92K | 9 month · $630.86K | (m) | (m) | (m) | (m) | $31.81M | (m) | (m) | (m) | (m) |
| 2017-06-30 | $40.69M | (m) | $-46.96M | (m) | (m) | (m) | 6 month · $444.17K | (m) | (m) | (m) | (m) | $1.75K | $-6.27M | (m) | (m) | (m) | (m) |
| 2017-03-31 | $38.96M | (m) | $-45.15M | (m) | (m) | (m) | 3 month · $228.04K | (m) | (m) | (m) | (m) | $1.44K | $-6.19M | (m) | (m) | (m) | (m) |
| 2016-12-31 | $37.98M | (m) | $-40.44M | (m) | (m) | (m) | 12 month · $717.93K | (m) | (m) | (m) | (m) | $1.40K | $-2.45M | (m) | (m) | (m) | (m) |
| 2016-09-30 | $36.49M | (m) | $-36.76M | (m) | (m) | (m) | 9 month · $478.44K | (m) | (m) | (m) | (m) | $1.18K | $-273.04K | (m) | (m) | (m) | (m) |
| 2016-06-30 | $34.91M | (m) | $-33.34M | (m) | (m) | (m) | 6 month · $229.06K | (m) | (m) | (m) | (m) | $1.08K | $1.57M | (m) | (m) | (m) | (m) |
| 2016-03-31 | $34.33M | (m) | $-29.69M | (m) | (m) | (m) | 3 month · $103.54K | (m) | (m) | (m) | (m) | $1.01K | $4.65M | (m) | (m) | (m) | (m) |
| 2015-12-31 | $30.10M | (m) | $-25.70M | (m) | (m) | (m) | 12 month · $992.16K | (m) | (m) | (m) | (m) | $812.00 | $4.40M | 12 month · $1.20M | (m) | (m) | (m) |
| 2015-09-30 | $29.94M | (m) | $-21.57M | (m) | (m) | (m) | 9 month · $828.05K | (m) | (m) | (m) | (m) | $812.00 | $8.37M | 9 month · $1.20M | (m) | (m) | (m) |
| 2015-06-30 | $29.72M | (m) | $-18.61M | (m) | (m) | (m) | 6 month · $627.85K | (m) | (m) | (m) | (m) | $812.00 | $11.11M | 6 month · $1.20M | (m) | (m) | (m) |
| 2015-03-31 | $1.49M | (m) | $-13.35M | (m) | (m) | (m) | 3 month · $52.62K | (m) | (m) | (m) | (m) | $288.00 | $-11.85M | 3 month · $202.52K | (m) | (m) | (m) |
| 2014-12-31 | $1.18M | (m) | $-9.41M | (m) | (m) | (m) | 12 month · $164.16K | 12 month · $114.30K | (m) | (m) | (m) | $288.00 | $-8.24M | 12 month · $614.56K | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-434.85K | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |